Theracryf Plc

0.17pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:TCFHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (38.50%)
Div yield —
ROE (81.30%)
Biotechnology
Beta (5Y) 1.40
PE TTM —
TSR TTM (19.05%)
Mkt cap £4.645M
ROIC (53.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
0.218p
28.01%
(97.77%)
Hold 9|6|12|11|9
3Q26
4Q26
1Q27
2Q27
Earnings per share£
—
—
—
—
7.03%
13.09%
12.67%
10.50%
Revenue£M
0.258
0.258
0.265
0.274
9.78%
8.17%
6.87%
10.31%
Peers (US$6.316M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
4.201
—
—
EBIT/Intx
0.566
0.286
0.237
Own earn%
1.22
(21.88)
(22.95)
Sh yield%
47.63
46.32
45.16
Owners
Insiders/Inst%
13.17
45.88
Short interest%
3.48
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
6–13
$1 testx
0.1
Incr. ROIC%
13